Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,804,724
-$40,002,262 QoQ
Shares Held
589,052
-6.3% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
11.95%
of 13F equity value
Holder Rank
#71
of 663 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$45,736,544
PutShares
279,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Artia Global Partners LP holds $407,350,933 across 37 Biotechnology names. INSM ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
516,447 | $68,821,727 | |
| 2 | INSM |
INSMED Inc
This page
|
589,052 | $62,804,724 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
2,210,852 | $41,232,389 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
185,390 | $34,719,839 | |
| 5 | ARGX |
Argenx SE
|
29,739 | $27,590,952 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
339,033 | $19,260,464 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
503,936 | $17,078,391 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
162,990 | $15,888,265 |
All Filings in INSM
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,804,724 | 589,052 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $45,736,544 | 279,700 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $102,806,986 | 628,712 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $118,732,176 | 682,212 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $73,096,800 | 420,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $57,604,000 | 400,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $105,445,850 | 732,212 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,025,600 | 40,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $75,752,935 | 752,712 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,278,453 | 318,239 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,594,508 | 167,939 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,864,547 | 52,939 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,580,212 | 53,436 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,207,742 | 118,236 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,322,266 | 74,936 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||